169 related articles for article (PubMed ID: 20215581)
1. Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary.
Cohen SM
Toxicol Pathol; 2010 Apr; 38(3):487-501. PubMed ID: 20215581
[TBL] [Abstract][Full Text] [Related]
2. Commentary on "Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary".
Long GG
Toxicol Pathol; 2010 Apr; 38(3):502-5. PubMed ID: 20124495
[No Abstract] [Full Text] [Related]
3. An enhanced 13-week bioassay: an alternative to the 2-year bioassay to screen for human carcinogenesis.
Cohen SM
Exp Toxicol Pathol; 2010 Sep; 62(5):497-502. PubMed ID: 19616417
[TBL] [Abstract][Full Text] [Related]
4. An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors.
Cohen SM
Asian Pac J Cancer Prev; 2010; 11(1):15-7. PubMed ID: 20593920
[TBL] [Abstract][Full Text] [Related]
5. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062
[TBL] [Abstract][Full Text] [Related]
6. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
7. Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay.
Cohen SM
Toxicol Sci; 2004 Aug; 80(2):225-9. PubMed ID: 15129023
[TBL] [Abstract][Full Text] [Related]
8. A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays.
Thomas RS; O'Connell TM; Pluta L; Wolfinger RD; Yang L; Page TJ
Toxicol Sci; 2007 Mar; 96(1):40-6. PubMed ID: 17114358
[TBL] [Abstract][Full Text] [Related]
9. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
10. Rapid bioassay methods for carcinogens and modifiers of hepatocarcinogenesis.
Ito N; Imaida K; Hasegawa R; Tsuda H
Crit Rev Toxicol; 1989; 19(4):385-415. PubMed ID: 2663023
[TBL] [Abstract][Full Text] [Related]
11. Prediction of rodent carcinogenesis: an evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies.
Allen DG; Pearse G; Haseman JK; Maronpot RR
Toxicol Pathol; 2004; 32(4):393-401. PubMed ID: 15307212
[TBL] [Abstract][Full Text] [Related]
12. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Aug; (530):1-258. PubMed ID: 17160104
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
14. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
18. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.
Flammang TJ; Tungeln LS; Kadlubar FF; Fu PP
Regul Toxicol Pharmacol; 1997 Oct; 26(2):230-40. PubMed ID: 9356286
[TBL] [Abstract][Full Text] [Related]
19. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
[TBL] [Abstract][Full Text] [Related]
20. Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents.
Ito N; Hasegawa R; Imaida K; Hirose M; Shirai T
Exp Toxicol Pathol; 1996 Feb; 48(2-3):113-9. PubMed ID: 8672864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]